Benzinga | Nov 9, 2021 11:29AM EST

Eagle Pharmaceuticals Q3 EPS $0.57 Misses $0.83 Estimate, Sales $39.90M Miss $46.40M Estimate

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.83 by 31.33 percent. This is a 51.28 percent decrease over earnings of $1.17 per share from the same period last year. The company reported quarterly sales of $39.90 million which missed the analyst consensus estimate of $46.40 million by 14.01 percent. This is a 20.08 percent decrease over sales of $49.93 million the same period last year.